Suvretta Capital Management, LLC 13D and 13G filings for Arcutis Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 12:29 pm Sale | 2023-12-31 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Suvretta Capital Management, LLC | 9,534,837 9.990% | -57,375 (-0.60%) | Filing |
| 2023-10-30 5:03 pm Purchase | 2023-10-20 | 13G | Arcutis Biotherapeutics, Inc. ARQT | Suvretta Capital Management, LLC | 9,592,212 9.990% | 9,592,212 (New Position) | Filing |